Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0H1YQ
|
||||
| Former ID |
DCL000664
|
||||
| Drug Name |
Xatral
|
||||
| Synonyms |
Alfetim; Alfoten; Urion; Uroxatral; Alfuzosin HCl; Alfuzosin Hydrochloride; Alfuzosin hydrochloride [USAN]; Xatral OD; Xatral Retard; Xatral SR; Xatral XL; SL 77 499-10; SL 77499-10; SL-77499; SL-7749910; Uroxatral (TN); Uroxatral, Alfuzosin hydrochloride; Alfuzosin hydrochloride (JAN/USAN); SL-77499-10; SL-77.0499-10; N-[3-[4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furancarboxamide hydrochloride; N-[3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)-methylamino]propyl]oxolane-2-carboxamide hydrochloride; N-{3-[(4-amino-6,7-dimethoxychinazolin-2-yl)(methyl)amino]propyl}tetrahydrofuran-2-carboxamidhydrochlorid; (+-)-N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furamide monohydrochloride
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Benign prostatic hyperplasia [ICD9: 600; ICD10:N40] | Approved | [551871] | ||
| Company |
Sanofi-Aventis
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C19H28ClN5O4
|
||||
| Canonical SMILES |
CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC.Cl
|
||||
| InChI |
1S/C19H27N5O4.ClH/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19;/h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23);1H
|
||||
| InChIKey |
YTNKWDJILNVLGX-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 81403-80-7
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
7848755, 8194817, 11528652, 12012888, 14758527, 43128042, 57318350, 78268148, 92125289, 92719118, 99004050, 99437262, 103679622, 103838871, 103914210, 104351250, 117539890, 124757231, 125164035, 125334025, 126621070, 126670423, 134223983, 134339185, 135029857, 135692140, 135698308, 136368114, 144115579, 144204252, 152106189, 162037591, 162179024, 163132546, 163564178, 164814685, 170465022, 175611078, 196110834, 198992200, 203355613, 210279324, 210281647, 223401659, 224081319, 226540787, 251912085, 251915158, 252157178, 252359239
|
||||
| SuperDrug ATC ID |
G04CA01
|
||||
| SuperDrug CAS ID |
cas=081403807
|
||||
| Target and Pathway | |||||
| Target(s) | Alpha-1A adrenergic receptor | Target Info | Antagonist | [549823] | |
| PANTHER Pathway | Alpha adrenergic receptor signaling pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.